{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:38:43Z","timestamp":1790109523081,"version":"4.0.1"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 2022S74XWB"],"award-info":[{"award-number":["PRIN 2022S74XWB"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["Missione 4 Componente 2 CUP I53D23005240006"],"award-info":[{"award-number":["Missione 4 Componente 2 CUP I53D23005240006"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["Next Generation EU"],"award-info":[{"award-number":["Next Generation EU"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["in the context of the National Recovery"],"award-info":[{"award-number":["in the context of the National Recovery"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["Resilience Plan"],"award-info":[{"award-number":["Resilience Plan"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["Investment PE8\u2014Project Age-It: \u201cAgeing Well in an Ageing Society"],"award-info":[{"award-number":["Investment PE8\u2014Project Age-It: \u201cAgeing Well in an Ageing Society"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["Next Generation EU - Italian NRRP"],"award-info":[{"award-number":["Next Generation EU - Italian NRRP"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["Mission 4"],"award-info":[{"award-number":["Mission 4"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["Component 2"],"award-info":[{"award-number":["Component 2"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["Investment 1.5"],"award-info":[{"award-number":["Investment 1.5"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["call for the creation"],"award-info":[{"award-number":["call for the creation"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["strengthening of 'Innovation Ecosystems'"],"award-info":[{"award-number":["strengthening of 'Innovation Ecosystems'"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["building 'Territorial R&D Leaders'"],"award-info":[{"award-number":["building 'Territorial R&D Leaders'"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003197","name":"Agenzia Italiana del Farmaco, Ministero della Salute","doi-asserted-by":"publisher","award":["PRIN 2022S74XWB"],"award-info":[{"award-number":["PRIN 2022S74XWB"]}],"id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003197","name":"Agenzia Italiana del Farmaco, Ministero della Salute","doi-asserted-by":"publisher","award":["Missione 4 Componente 2 CUP I53D23005240006"],"award-info":[{"award-number":["Missione 4 Componente 2 CUP I53D23005240006"]}],"id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Basic Res Cardiol"],"DOI":"10.1007\/s00395-026-01177-6","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:41:07Z","timestamp":1776422467000},"page":"371-393","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Empagliflozin improves metabolism and prevents myocardial and coronary dysfunction in streptozotocin-diabetic and non-diabetic rats subjected to ischemia\/reperfusion"],"prefix":"10.1007","volume":"121","author":[{"given":"Carmine","family":"Rocca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"De Bartolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Granieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Rago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Conforti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Urlandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Mattii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Pagliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Angelone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Penna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinda","family":"Madonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"1177_CR1","doi-asserted-by":"publisher","DOI":"10.3791\/61122","author":"J Aguilar Diaz De Leon","year":"2020","unstructured":"Aguilar Diaz De Leon J, Borges CR (2020) Evaluation of oxidative stress in biological samples using the thiobarbituric acid reactive substances assay. J Vis Exp. https:\/\/doi.org\/10.3791\/61122","journal-title":"J Vis Exp"},{"key":"1177_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111624","volume":"139","author":"AS Ahmed","year":"2021","unstructured":"Ahmed AS, Mona MM, Abdel-Kareem MA, Elsisy RA (2021) SGLT2 inhibitor empagliflozin monotherapy alleviates renal oxidative stress in albino Wistar diabetic rats after myocardial infarction induction. Biomed Pharmacother 139:111624. https:\/\/doi.org\/10.1016\/j.biopha.2021.111624","journal-title":"Biomed Pharmacother"},{"key":"1177_CR3","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1210\/jc.2017-01838","volume":"103","author":"H Al Jobori","year":"2018","unstructured":"Al Jobori H, Daniele G, Adams J, Cersosimo E, Solis-Herrera C, Triplitt C, DeFronzo RA, Abdul-Ghani M (2018) Empagliflozin treatment is associated with improved \u03b2-cell function in type 2 diabetes mellitus. J Clin Endocrinol Metab 103:1402\u20131407. https:\/\/doi.org\/10.1210\/jc.2017-01838","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"1177_CR4","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.2337\/dc09-S062","volume":"32","author":"American Diabetes Association","year":"2009","unstructured":"American Diabetes Association (2009) Diagnosis and classification of diabetes mellitus. Diabetes Care 32(Suppl 1):S62-67. https:\/\/doi.org\/10.2337\/dc09-S062","journal-title":"Diabetes Care"},{"key":"1177_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165770","volume":"1866","author":"I Andreadou","year":"2020","unstructured":"Andreadou I, Bell RM, B\u00f8tker HE, Zuurbier CJ (2020) SGLT2 inhibitors reduce infarct size in reperfused ischemic heart and improve cardiac function during ischemic episodes in preclinical models. Biochim Biophys Acta Mol Basis Dis 1866:165770. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165770","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1177_CR6","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3389\/fphys.2017.01077","volume":"8","author":"I Andreadou","year":"2017","unstructured":"Andreadou I, Efentakis P, Balafas E, Togliatto G, Davos CH, Varela A, Dimitriou CA, Nikolaou P-E, Maratou E, Lambadiari V, Ikonomidis I, Kostomitsopoulos N, Brizzi MF, Dimitriadis G, Iliodromitis EK (2017) Empagliflozin limits myocardial infarction in vivo and cell death in vitro: role of STAT3, mitochondria, and redox aspects. Front Physiol 8:1077. https:\/\/doi.org\/10.3389\/fphys.2017.01077","journal-title":"Front Physiol"},{"key":"1177_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1089\/ars.2023.0285","volume":"40","author":"T Angelone","year":"2024","unstructured":"Angelone T, Rocca C, Lionetti V, Penna C, Pagliaro P (2024) Expanding the frontiers of guardian antioxidant selenoproteins in cardiovascular pathophysiology. Antioxid Redox Signal 40:369\u2013432. https:\/\/doi.org\/10.1089\/ars.2023.0285","journal-title":"Antioxid Redox Signal"},{"key":"1177_CR8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/path.4113","volume":"229","author":"DM Ansley","year":"2013","unstructured":"Ansley DM, Wang B (2013) Oxidative stress and myocardial injury in the diabetic heart. J Pathol 229:232\u2013241. https:\/\/doi.org\/10.1002\/path.4113","journal-title":"J Pathol"},{"key":"1177_CR9","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1161\/CIRCULATIONAHA.113.002114","volume":"128","author":"EJ Armstrong","year":"2013","unstructured":"Armstrong EJ, Rutledge JC, Rogers JH (2013) Coronary artery revascularization in patients with diabetes mellitus. Circulation 128:1675\u20131685. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.002114","journal-title":"Circulation"},{"key":"1177_CR10","doi-asserted-by":"publisher","first-page":"4920","DOI":"10.1210\/jc.2005-0664","volume":"90","author":"A Ashraf","year":"2005","unstructured":"Ashraf A, Mick G, Meleth S, Abdullatif H, Wang X, McCormick K (2005) Effect of insulin on plasma vascular endothelial growth factor in children with new-onset diabetes. J Clin Endocrinol Metab 90:4920\u20134923. https:\/\/doi.org\/10.1210\/jc.2005-0664","journal-title":"J Clin Endocrinol Metab"},{"key":"1177_CR11","doi-asserted-by":"publisher","first-page":"11596","DOI":"10.1074\/jbc.M109.076984","volume":"285","author":"X Ba","year":"2010","unstructured":"Ba X, Gupta S, Davidson M, Garg NJ (2010) Trypanosoma cruzi induces the reactive oxygen species-PARP-1-RelA pathway for up-regulation of cytokine expression in cardiomyocytes. J Biol Chem 285:11596\u201311606. https:\/\/doi.org\/10.1074\/jbc.M109.076984","journal-title":"J Biol Chem"},{"key":"1177_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096117","volume":"9","author":"X Bai","year":"2014","unstructured":"Bai X, Li X, Tian J, Zhou Z (2014) Antiangiogenic treatment diminishes renal injury and dysfunction via regulation of local AKT in early experimental diabetes. PLoS ONE 9:e96117. https:\/\/doi.org\/10.1371\/journal.pone.0096117","journal-title":"PLoS ONE"},{"key":"1177_CR13","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1161\/01.res.0000012702.90501.8d","volume":"90","author":"CP Baines","year":"2002","unstructured":"Baines CP, Zhang J, Wang G-W, Zheng Y-T, Xiu JX, Cardwell EM, Bolli R, Ping P (2002) Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. Circ Res 90:390\u2013397. https:\/\/doi.org\/10.1161\/01.res.0000012702.90501.8d","journal-title":"Circ Res"},{"key":"1177_CR14","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.3390\/biomedicines10071751","volume":"10","author":"AA Berezin","year":"2022","unstructured":"Berezin AA, Fushtey IM, Berezin AE (2022) The effect of SGLT2 inhibitor Dapagliflozin on serum levels of apelin in T2DM patients with heart failure. Biomedicines 10:1751. https:\/\/doi.org\/10.3390\/biomedicines10071751","journal-title":"Biomedicines"},{"key":"1177_CR15","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00395-024-01060-2","volume":"119","author":"E Bertero","year":"2024","unstructured":"Bertero E, Popoiu T-A, Maack C (2024) Mitochondrial calcium in cardiac ischemia\/reperfusion injury and cardioprotection. Basic Res Cardiol 119:569\u2013585. https:\/\/doi.org\/10.1007\/s00395-024-01060-2","journal-title":"Basic Res Cardiol"},{"key":"1177_CR16","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00395-010-0124-1","volume":"105","author":"K Boengler","year":"2010","unstructured":"Boengler K, Hilfiker-Kleiner D, Heusch G, Schulz R (2010) Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia\/reperfusion. Basic Res Cardiol 105:771\u2013785. https:\/\/doi.org\/10.1007\/s00395-010-0124-1","journal-title":"Basic Res Cardiol"},{"key":"1177_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.103010","volume":"69","author":"W Cai","year":"2024","unstructured":"Cai W, Chong K, Huang Y, Huang C, Yin L (2024) Empagliflozin improves mitochondrial dysfunction in diabetic cardiomyopathy by modulating ketone body metabolism and oxidative stress. Redox Biol 69:103010. https:\/\/doi.org\/10.1016\/j.redox.2023.103010","journal-title":"Redox Biol"},{"key":"1177_CR18","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00395-024-01067-9","volume":"119","author":"S Chen","year":"2024","unstructured":"Chen S, Wang Q, Bakker D, Hu X, Zhang L, van der Made I, Tebbens AM, Kov\u00e1csh\u00e1zi C, Giricz Z, Brenner GB, Ferdinandy P, Schaart G, Gemmink A, Hesselink MKC, Rivaud MR, Pieper MP, Hollmann MW, Weber NC, Balligand J-L, Creemers EE, Coronel R, Zuurbier CJ (2024) Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2. Basic Res Cardiol 119:751\u2013772. https:\/\/doi.org\/10.1007\/s00395-024-01067-9","journal-title":"Basic Res Cardiol"},{"key":"1177_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1161\/CIRCULATIONAHA.122.061688","volume":"147","author":"S Chen","year":"2023","unstructured":"Chen S, Wang Q, Christodoulou A, Mylonas N, Bakker D, Nederlof R, Hollmann MW, Weber NC, Coronel R, Wakker V, Christoffels VM, Andreadou I, Zuurbier CJ (2023) Sodium glucose cotransporter-2 inhibitor Empagliflozin reduces infarct size independently of sodium glucose cotransporter-2. Circulation 147:276\u2013279. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.061688","journal-title":"Circulation"},{"key":"1177_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147391","volume":"11","author":"STW Cheng","year":"2016","unstructured":"Cheng STW, Chen L, Li SYT, Mayoux E, Leung PS (2016) The effects of Empagliflozin, an SGLT2 inhibitor, on pancreatic \u03b2-cell mass and glucose homeostasis in type 1 diabetes. PLoS ONE 11:e0147391. https:\/\/doi.org\/10.1371\/journal.pone.0147391","journal-title":"PLoS ONE"},{"key":"1177_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.117967","volume":"185","author":"N Chorazy","year":"2025","unstructured":"Chorazy N, Wojnar-Lason K, Gdula AM, Bakker D, Zuurbier CJ, Chlopicki S, Pacia MZ (2025) Sodium-glucose co-transporters (SGLT2) inhibitors prevent lipid droplets formation in vascular inflammation or lipid overload by SGLT2-independent mechanism. Biomed Pharmacother 185:117967. https:\/\/doi.org\/10.1016\/j.biopha.2025.117967","journal-title":"Biomed Pharmacother"},{"key":"1177_CR22","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41569-020-0406-8","volume":"17","author":"MR Cowie","year":"2020","unstructured":"Cowie MR, Fisher M (2020) SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control. Nat Rev Cardiol 17:761\u2013772. https:\/\/doi.org\/10.1038\/s41569-020-0406-8","journal-title":"Nat Rev Cardiol"},{"key":"1177_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2025.107462","volume":"158","author":"A De Bartolo","year":"2025","unstructured":"De Bartolo A, Angelone T, Rocca C (2025) Elucidating emerging signaling pathways driving endothelial dysfunction in cardiovascular aging. Vascul Pharmacol 158:107462. https:\/\/doi.org\/10.1016\/j.vph.2025.107462","journal-title":"Vascul Pharmacol"},{"key":"1177_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05192-w","volume":"22","author":"A De Bartolo","year":"2024","unstructured":"De Bartolo A, Pasqua T, Romeo N, Rago V, Perrotta I, Giordano F, Granieri MC, Marrone A, Mazza R, Cerra MC, Lefranc B, Leprince J, Anouar Y, Angelone T, Rocca C (2024) The redox-active defensive Selenoprotein T as a novel stress sensor protein playing a key role in the pathophysiology of heart failure. J Transl Med 22:375. https:\/\/doi.org\/10.1186\/s12967-024-05192-w","journal-title":"J Transl Med"},{"key":"1177_CR25","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41401-024-01397-3","volume":"46","author":"A De Bartolo","year":"2025","unstructured":"De Bartolo A, Romeo N, Marrone A, Rago V, Granieri MC, Vommaro ML, Cupelli A, Cerra MC, Indiveri C, Ronca R, Cantile M, Sanna R, Rocca C, Angelone T (2025) A recombinant fragment antigen-binding (Fab) of trastuzumab displays low cytotoxic profile in adult human cardiomyocytes: first evidence and the key implication of Fc\u03b3RIIA receptor. Acta Pharmacol Sin 46:618\u2013631. https:\/\/doi.org\/10.1038\/s41401-024-01397-3","journal-title":"Acta Pharmacol Sin"},{"key":"1177_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3790721","volume":"2022","author":"K Ding","year":"2022","unstructured":"Ding K, Song C, Hu H, Yin K, Huang H, Tang H (2022) The role of NLRP3 inflammasome in diabetic cardiomyopathy and its therapeutic implications. Oxid Med Cell Longev 2022:3790721. https:\/\/doi.org\/10.1155\/2022\/3790721","journal-title":"Oxid Med Cell Longev"},{"key":"1177_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/10715762.2021.1937146","volume":"55","author":"Z Fei","year":"2021","unstructured":"Fei Z, Gao W, Xu X, Sheng H, Qu S, Cui R (2021) Serum superoxide dismutase activity: a sensitive, convenient, and economical indicator associated with the prevalence of chronic type 2 diabetic complications, especially in men. Free Radic Res 55:275\u2013281. https:\/\/doi.org\/10.1080\/10715762.2021.1937146","journal-title":"Free Radic Res"},{"key":"1177_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.78","volume":"1","author":"BL Furman","year":"2021","unstructured":"Furman BL (2021) Streptozotocin-induced diabetic models in mice and rats. Curr Protoc 1:e78. https:\/\/doi.org\/10.1002\/cpz1.78","journal-title":"Curr Protoc"},{"key":"1177_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115542","volume":"257","author":"S Gastaldi","year":"2023","unstructured":"Gastaldi S, Rocca C, Gianquinto E, Granieri MC, Boscaro V, Blua F, Rolando B, Marini E, Gallicchio M, De Bartolo A, Romeo N, Mazza R, Fedele F, Pagliaro P, Penna C, Spyrakis F, Bertinaria M, Angelone T (2023) Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation. Eur J Med Chem 257:115542. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115542","journal-title":"Eur J Med Chem"},{"key":"1177_CR30","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.jacc.2004.06.071","volume":"44","author":"RJ Gibbons","year":"2004","unstructured":"Gibbons RJ, Valeti US, Araoz PA, Jaffe AS (2004) The quantification of infarct size. J Am Coll Cardiol 44:1533\u20131542. https:\/\/doi.org\/10.1016\/j.jacc.2004.06.071","journal-title":"J Am Coll Cardiol"},{"key":"1177_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1463-1326.2011.01517.x","volume":"14","author":"R Grempler","year":"2012","unstructured":"Grempler R, Thomas L, Eckhardt M, Himmelsbach F, Sauer A, Sharp DE, Bakker RA, Mark M, Klein T, Eickelmann P (2012) Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors. Diabetes Obes Metab 14:83\u201390. https:\/\/doi.org\/10.1111\/j.1463-1326.2011.01517.x","journal-title":"Diabetes Obes Metab"},{"key":"1177_CR32","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1161\/01.cir.100.10.1134","volume":"100","author":"SM Grundy","year":"1999","unstructured":"Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC, Sowers JR (1999) Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100:1134\u20131146. https:\/\/doi.org\/10.1161\/01.cir.100.10.1134","journal-title":"Circulation"},{"key":"1177_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-023-01019-9","volume":"118","author":"S Hernandez-Resendiz","year":"2023","unstructured":"Hernandez-Resendiz S, Prakash A, Loo SJ, Semenzato M, Chinda K, Crespo-Avilan GE, Dam LC, Lu S, Scorrano L, Hausenloy DJ (2023) Targeting mitochondrial shape: at the heart of cardioprotection. Basic Res Cardiol 118:49. https:\/\/doi.org\/10.1007\/s00395-023-01019-9","journal-title":"Basic Res Cardiol"},{"key":"1177_CR34","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","volume":"17","author":"G Heusch","year":"2020","unstructured":"Heusch G (2020) Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol 17:773\u2013789. https:\/\/doi.org\/10.1038\/s41569-020-0403-y","journal-title":"Nat Rev Cardiol"},{"key":"1177_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-022-00909-8","volume":"117","author":"G Heusch","year":"2022","unstructured":"Heusch G (2022) Coronary blood flow in heart failure: cause, consequence and bystander. Basic Res Cardiol 117:1. https:\/\/doi.org\/10.1007\/s00395-022-00909-8","journal-title":"Basic Res Cardiol"},{"key":"1177_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jacbts.2024.08.010","volume":"10","author":"G Heusch","year":"2025","unstructured":"Heusch G, Kleinbongard P (2025) The enigmata of cardioprotection with SGLT2 inhibition. JACC Basic Transl Sci 10:62\u201364. https:\/\/doi.org\/10.1016\/j.jacbts.2024.08.010","journal-title":"JACC Basic Transl Sci"},{"key":"1177_CR37","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/s0735-1097(01)01138-x","volume":"37","author":"WB Hillegass","year":"2001","unstructured":"Hillegass WB, Dean NA, Liao L, Rhinehart RG, Myers PR (2001) Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience. J Am Coll Cardiol 37:1335\u20131343. https:\/\/doi.org\/10.1016\/s0735-1097(01)01138-x","journal-title":"J Am Coll Cardiol"},{"key":"1177_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01553-4","volume":"9","author":"J-L Huo","year":"2023","unstructured":"Huo J-L, Feng Q, Pan S, Fu W-J, Liu Z, Liu Z (2023) Diabetic cardiomyopathy: early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions. Cell Death Discov 9:256. https:\/\/doi.org\/10.1038\/s41420-023-01553-4","journal-title":"Cell Death Discov"},{"key":"1177_CR39","unstructured":"Impairment of insulin-mediated glucose metabolism by hyperosmolality in man - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/6416909\/. Accessed 28 May 2025"},{"key":"1177_CR40","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015716","volume":"9","author":"I Ikonomidis","year":"2020","unstructured":"Ikonomidis I, Pavlidis G, Thymis J, Birba D, Kalogeris A, Kousathana F, Kountouri A, Balampanis K, Parissis J, Andreadou I, Katogiannis K, Dimitriadis G, Bamias A, Iliodromitis E, Lambadiari V (2020) Effects of Glucagon-Like Peptide-1 receptor agonists, Sodium-Glucose Cotransporter-2 inhibitors, and their combination on endothelial glycocalyx, arterial function, and myocardial work index in patients with Type 2 Diabetes Mellitus after 12-month treatment. J Am Heart Assoc 9:e015716. https:\/\/doi.org\/10.1161\/JAHA.119.015716","journal-title":"J Am Heart Assoc"},{"key":"1177_CR41","doi-asserted-by":"publisher","first-page":"E1030","DOI":"10.1152\/ajpendo.00517.2006","volume":"292","author":"S Jesmin","year":"2007","unstructured":"Jesmin S, Zaedi S, Shimojo N, Iemitsu M, Masuzawa K, Yamaguchi N, Mowa CN, Maeda S, Hattori Y, Miyauchi T (2007) Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts. Am J Physiol Endocrinol Metab 292:E1030-1040. https:\/\/doi.org\/10.1152\/ajpendo.00517.2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1177_CR42","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR (2018) Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res 122:624\u2013638. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311586","journal-title":"Circ Res"},{"key":"1177_CR43","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s13238-020-00809-4","volume":"13","author":"K Jiang","year":"2022","unstructured":"Jiang K, Xu Y, Wang D, Chen F, Tu Z, Qian J, Xu S, Xu Y, Hwa J, Li J, Shang H, Xiang Y (2022) Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis. Protein Cell 13:336\u2013359. https:\/\/doi.org\/10.1007\/s13238-020-00809-4","journal-title":"Protein Cell"},{"key":"1177_CR44","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jacbts.2019.04.003","volume":"4","author":"RP Juni","year":"2019","unstructured":"Juni RP, Kuster DWD, Goebel M, Helmes M, Musters RJP, van der Velden J, Koolwijk P, Paulus WJ, van Hinsbergh VWM (2019) Cardiac microvascular endothelial enhancement of cardiomyocyte function is impaired by inflammation and restored\u00a0by Empagliflozin. JACC Basic Transl Sci 4:575\u2013591. https:\/\/doi.org\/10.1016\/j.jacbts.2019.04.003","journal-title":"JACC Basic Transl Sci"},{"key":"1177_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-12-139","volume":"12","author":"I Khaliulin","year":"2014","unstructured":"Khaliulin I, Halestrap AP, Bryant SM, Dudley DJ, James AF, Suleiman M-S (2014) Clinically-relevant consecutive treatment with isoproterenol and adenosine protects the failing heart against ischaemia and reperfusion. J Transl Med 12:139. https:\/\/doi.org\/10.1186\/1479-5876-12-139","journal-title":"J Transl Med"},{"key":"1177_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-017-0660-z","volume":"113","author":"P Kleinbongard","year":"2018","unstructured":"Kleinbongard P, Skyschally A, Gent S, Pesch M, Heusch G (2018) STAT3 as a common signal of ischemic conditioning: a lesson on \u201crigor and reproducibility\u201d in preclinical studies on cardioprotection. Basic Res Cardiol 113:3. https:\/\/doi.org\/10.1007\/s00395-017-0660-z","journal-title":"Basic Res Cardiol"},{"key":"1177_CR47","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cardfail.2013.01.013","volume":"19","author":"YE Koshman","year":"2013","unstructured":"Koshman YE, Patel N, Chu M, Iyengar R, Kim T, Ersahin C, Lewis W, Heroux A, Samarel AM (2013) Regulation of connective tissue growth factor gene expression and fibrosis in human heart failure. J Card Fail 19:283\u2013294. https:\/\/doi.org\/10.1016\/j.cardfail.2013.01.013","journal-title":"J Card Fail"},{"key":"1177_CR48","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3390\/antiox10091379","volume":"10","author":"V Lambadiari","year":"2021","unstructured":"Lambadiari V, Thymis J, Kouretas D, Skaperda Z, Tekos F, Kousathana F, Kountouri A, Balampanis K, Parissis J, Andreadou I, Tsoumani M, Chania C, Katogiannis K, Dimitriadis G, Bamias A, Ikonomidis I (2021) Effects of a 12-month treatment with glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, and their combination on oxidant and antioxidant biomarkers in patients with type 2 diabetes. Antioxidants (Basel) 10:1379. https:\/\/doi.org\/10.3390\/antiox10091379","journal-title":"Antioxidants (Basel)"},{"key":"1177_CR49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.yjmcc.2015.12.020","volume":"91","author":"A Lejay","year":"2016","unstructured":"Lejay A, Fang F, John R, Van JAD, Barr M, Thaveau F, Chakfe N, Geny B, Scholey JW (2016) Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus. J Mol Cell Cardiol 91:11\u201322. https:\/\/doi.org\/10.1016\/j.yjmcc.2015.12.020","journal-title":"J Mol Cell Cardiol"},{"key":"1177_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102979","volume":"69","author":"X Li","year":"2024","unstructured":"Li X, Wang M, Kalina J-O, Preckel B, Hollmann MW, Albrecht M, Zuurbier CJ, Weber NC (2024) Empagliflozin prevents oxidative stress in human coronary artery endothelial cells via the NHE\/PKC\/NOX axis. Redox Biol 69:102979. https:\/\/doi.org\/10.1016\/j.redox.2023.102979","journal-title":"Redox Biol"},{"key":"1177_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.177147","volume":"986","author":"X Li","year":"2025","unstructured":"Li X, Wang M, Wolfsgruber M, Klatt OC, Hollmann MW, Preckel B, Zuurbier CJ, Weber NC (2025) Empagliflozin prevents TNF-\u03b1 induced endothelial dysfunction under flow -the potential involvement of calcium and sodium-hydrogen exchanger. Eur J Pharmacol 986:177147. https:\/\/doi.org\/10.1016\/j.ejphar.2024.177147","journal-title":"Eur J Pharmacol"},{"key":"1177_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23034","volume":"36","author":"Z Li","year":"2022","unstructured":"Li Z, Zhao J, Li H, Li Y, Lin C (2022) Catalpol protects AC16 cells from hypoxia\/reoxygenation injury by regulating the miR-22-3p\/DPP4 axis. J Biochem Mol Toxicol 36:e23034. https:\/\/doi.org\/10.1002\/jbt.23034","journal-title":"J Biochem Mol Toxicol"},{"key":"1177_CR53","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41569-025-01163-w","volume":"22","author":"L Liberale","year":"2025","unstructured":"Liberale L, Duncker DJ, Hausenloy DJ, Kraler S, B\u00f8tker HE, Podesser BK, Heusch G, Kleinbongard P (2025) Vascular (dys)function in the failing heart. Nat Rev Cardiol 22:728\u2013750. https:\/\/doi.org\/10.1038\/s41569-025-01163-w","journal-title":"Nat Rev Cardiol"},{"key":"1177_CR54","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jacbts.2018.10.002","volume":"4","author":"VG Lim","year":"2019","unstructured":"Lim VG, Bell RM, Arjun S, Kolatsi-Joannou M, Long DA, Yellon DM (2019) SGLT2 inhibitor, Canagliflozin, attenuates myocardial infarction in the diabetic and nondiabetic heart. JACC Basic Transl Sci 4:15\u201326. https:\/\/doi.org\/10.1016\/j.jacbts.2018.10.002","journal-title":"JACC Basic Transl Sci"},{"key":"1177_CR55","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.jacc.2022.11.001","volume":"80","author":"M Lindstrom","year":"2022","unstructured":"Lindstrom M, DeCleene N, Dorsey H, Fuster V, Johnson CO, LeGrand KE, Mensah GA, Razo C, Stark B, Varieur Turco J, Roth GA (2022) Global burden of cardiovascular diseases and risks collaboration, 1990\u20132021. J Am Coll Cardiol 80:2372\u20132425. https:\/\/doi.org\/10.1016\/j.jacc.2022.11.001","journal-title":"J Am Coll Cardiol"},{"key":"1177_CR56","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","volume":"5","author":"GD Lopaschuk","year":"2020","unstructured":"Lopaschuk GD, Verma S (2020) Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review. JACC Basic Transl Sci 5:632\u2013644. https:\/\/doi.org\/10.1016\/j.jacbts.2020.02.004","journal-title":"JACC Basic Transl Sci"},{"key":"1177_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2022.106993","volume":"144","author":"R Madonna","year":"2022","unstructured":"Madonna R (2022) Angiocrine endothelium: from physiology to atherosclerosis and cardiac repair. Vascul Pharmacol 144:106993. https:\/\/doi.org\/10.1016\/j.vph.2022.106993","journal-title":"Vascul Pharmacol"},{"key":"1177_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2023.107242","volume":"153","author":"R Madonna","year":"2023","unstructured":"Madonna R (2023) Endothelial heterogeneity and their relevance in cardiac development and coronary artery disease. Vascul Pharmacol 153:107242. https:\/\/doi.org\/10.1016\/j.vph.2023.107242","journal-title":"Vascul Pharmacol"},{"key":"1177_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116650","volume":"175","author":"R Madonna","year":"2024","unstructured":"Madonna R, Biondi F, Alberti M, Ghelardoni S, Mattii L, D\u2019Alleva A (2024) Cardiovascular outcomes and molecular targets for the cardiac effects of sodium-glucose cotransporter 2 inhibitors: a systematic review. Biomed Pharmacother 175:116650. https:\/\/doi.org\/10.1016\/j.biopha.2024.116650","journal-title":"Biomed Pharmacother"},{"key":"1177_CR60","doi-asserted-by":"publisher","first-page":"12331","DOI":"10.1111\/jcmm.15699","volume":"24","author":"R Madonna","year":"2020","unstructured":"Madonna R, Doria V, Minnucci I, Pucci A, Pierdomenico DS, De Caterina R (2020) Empagliflozin reduces the senescence of cardiac stromal cells and improves cardiac function in a murine model of diabetes. J Cell Mol Med 24:12331\u201312340. https:\/\/doi.org\/10.1111\/jcmm.15699","journal-title":"J Cell Mol Med"},{"key":"1177_CR61","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/cvr\/cvad009","volume":"119","author":"R Madonna","year":"2023","unstructured":"Madonna R, Moscato S, Cufaro MC, Pieragostino D, Mattii L, Del Boccio P, Ghelardoni S, Zucchi R, De Caterina R (2023) Empagliflozin inhibits excessive autophagy through the AMPK\/GSK3\u03b2 signalling pathway in diabetic cardiomyopathy. Cardiovasc Res 119:1175\u20131189. https:\/\/doi.org\/10.1093\/cvr\/cvad009","journal-title":"Cardiovasc Res"},{"key":"1177_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2020.106678","volume":"130","author":"R Madonna","year":"2020","unstructured":"Madonna R, Pieragostino D, Rossi C, Confalone P, Cicalini I, Minnucci I, Zucchelli M, Del Boccio P, De Caterina R (2020) Simulated hyperglycemia impairs insulin signaling in endothelial cells through a hyperosmolar mechanism. Vascul Pharmacol 130:106678. https:\/\/doi.org\/10.1016\/j.vph.2020.106678","journal-title":"Vascul Pharmacol"},{"key":"1177_CR63","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1161\/CIRCULATIONAHA.105.572552","volume":"112","author":"A Maloyan","year":"2005","unstructured":"Maloyan A, Sanbe A, Osinska H, Westfall M, Robinson D, Imahashi K, Murphy E, Robbins J (2005) Mitochondrial dysfunction and apoptosis underlie the pathogenic process in alpha-B-crystallin desmin-related cardiomyopathy. Circulation 112:3451\u20133461. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.572552","journal-title":"Circulation"},{"key":"1177_CR64","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1161\/CIRCRESAHA.123.321872","volume":"132","author":"TR Matsuura","year":"2023","unstructured":"Matsuura TR, Puchalska P, Crawford PA, Kelly DP (2023) Ketones and the heart: metabolic principles and therapeutic implications. Circ Res 132:882\u2013898. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.321872","journal-title":"Circ Res"},{"key":"1177_CR65","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.yjmcc.2010.02.001","volume":"49","author":"R McIntosh","year":"2010","unstructured":"McIntosh R, Lee S, Ghio AJ, Xi J, Zhu M, Shen X, Chanoit G, Zvara DA, Xu Z (2010) The critical role of intracellular zinc in adenosine A(2) receptor activation induced cardioprotection against reperfusion injury. J Mol Cell Cardiol 49:41\u201347. https:\/\/doi.org\/10.1016\/j.yjmcc.2010.02.001","journal-title":"J Mol Cell Cardiol"},{"key":"1177_CR66","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/000456327200900102","volume":"9","author":"MJ McQueen","year":"1972","unstructured":"McQueen MJ (1972) Optimal assay of LDH and \u03b1-HBD at 37 \u00b0C. Ann Clin Biochem 9:21\u201325. https:\/\/doi.org\/10.1177\/000456327200900102","journal-title":"Ann Clin Biochem"},{"key":"1177_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-11-67","volume":"11","author":"T Miki","year":"2012","unstructured":"Miki T, Itoh T, Sunaga D, Miura T (2012) Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning. Cardiovasc Diabetol 11:67. https:\/\/doi.org\/10.1186\/1475-2840-11-67","journal-title":"Cardiovasc Diabetol"},{"key":"1177_CR68","doi-asserted-by":"publisher","first-page":"H751","DOI":"10.1152\/ajpheart.00260.2021","volume":"321","author":"PK Mishra","year":"2021","unstructured":"Mishra PK (2021) Why the diabetic heart is energy inefficient: a ketogenesis and ketolysis perspective. Am J Physiol Heart Circ Physiol 321:H751\u2013H755. https:\/\/doi.org\/10.1152\/ajpheart.00260.2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1177_CR69","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.bbamcr.2012.08.009","volume":"1833","author":"C Montessuit","year":"2013","unstructured":"Montessuit C, Lerch R (2013) Regulation and dysregulation of glucose transport in cardiomyocytes. Biochim Biophys Acta 1833:848\u2013856. https:\/\/doi.org\/10.1016\/j.bbamcr.2012.08.009","journal-title":"Biochim Biophys Acta"},{"key":"1177_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2025.120404","volume":"407","author":"N Mylonas","year":"2025","unstructured":"Mylonas N, Nikolaou PE, Siokatas G, Kostopoulos IV, Tsitsilonis O, Drosatos K, Andreadou I (2025) Empagliflozin restores cardiac metabolism and suppresses immune activation in acute myocardial infarction. Atherosclerosis 407:120404. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120404","journal-title":"Atherosclerosis"},{"key":"1177_CR71","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002347","volume":"5","author":"M Nayor","year":"2015","unstructured":"Nayor M, Wang N, Larson MG, Vasan RS, Levy D, Ho JE (2015) Circulating Galectin-3 is associated with cardiometabolic disease in the community. J Am Heart Assoc 5:e002347. https:\/\/doi.org\/10.1161\/JAHA.115.002347","journal-title":"J Am Heart Assoc"},{"key":"1177_CR72","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jnutbio.2019.03.019","volume":"69","author":"IC Nettore","year":"2019","unstructured":"Nettore IC, Rocca C, Mancino G, Albano L, Amelio D, Grande F, Puoci F, Pasqua T, Desiderio S, Mazza R, Terracciano D, Colao A, B\u00e8guinot F, Russo GL, Dentice M, Macchia PE, Sinicropi MS, Angelone T, Ungaro P (2019) Quercetin and its derivative Q2 modulate chromatin dynamics in adipogenesis and Q2 prevents obesity and metabolic disorders in rats. J Nutr Biochem 69:151\u2013162. https:\/\/doi.org\/10.1016\/j.jnutbio.2019.03.019","journal-title":"J Nutr Biochem"},{"key":"1177_CR73","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1089\/ars.2019.7923","volume":"34","author":"PE Nikolaou","year":"2021","unstructured":"Nikolaou PE, Efentakis P, Abu Qourah F, Femmin\u00f2 S, Makridakis M, Kanaki Z, Varela A, Tsoumani M, Davos CH, Dimitriou CA, Tasouli A, Dimitriadis G, Kostomitsopoulos N, Zuurbier CJ, Vlahou A, Klinakis A, Brizzi MF, Iliodromitis EK, Andreadou I (2021) Chronic Empagliflozin treatment reduces myocardial infarct size in nondiabetic mice through STAT-3-mediated protection on microvascular endothelial cells and reduction of oxidative stress. Antioxid Redox Signal 34:551\u2013571. https:\/\/doi.org\/10.1089\/ars.2019.7923","journal-title":"Antioxid Redox Signal"},{"key":"1177_CR74","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jacbts.2024.08.003","volume":"10","author":"PE Nikolaou","year":"2025","unstructured":"Nikolaou PE, Konijnenberg LSF, Kostopoulos IV, Miliotis M, Mylonas N, Georgoulis A, Pavlidis G, Kuster CTA, van Reijmersdal VPA, Luiken TTJ, Agapaki A, Roverts R, Orologas N, Grigoriadis D, Pallot G, Boucher P, Kostomitsopoulos N, Pieper MP, Germain S, Loukas Y, Dotsikas Y, Ikonomidis I, Hatzigeorgiou AG, Tsitsilonis O, Zuurbier CJ, Nijveldt R, van Royen N, Andreadou I (2025) Empagliflozin in acute myocardial infarction reduces no-reflow and preserves cardiac function by preventing endothelial damage. JACC Basic Transl Sci 10:43\u201361. https:\/\/doi.org\/10.1016\/j.jacbts.2024.08.003","journal-title":"JACC Basic Transl Sci"},{"key":"1177_CR75","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-022-00934-7","volume":"117","author":"PE Nikolaou","year":"2022","unstructured":"Nikolaou PE, Mylonas N, Makridakis M, Makrecka-Kuka M, Iliou A, Zerikiotis S, Efentakis P, Kampoukos S, Kostomitsopoulos N, Vilskersts R, Ikonomidis I, Lambadiari V, Zuurbier CJ, Latosinska A, Vlahou A, Dimitriadis G, Iliodromitis EK, Andreadou I (2022) Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia\/reperfusion injury: a class or a drug effect? Basic Res Cardiol 117:27. https:\/\/doi.org\/10.1007\/s00395-022-00934-7","journal-title":"Basic Res Cardiol"},{"key":"1177_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2023.114432","volume":"366","author":"I Olivito","year":"2023","unstructured":"Olivito I, Avolio E, Minervini D, Soda T, Rocca C, Angelone T, Iaquinta FS, Bellizzi D, De Rango F, Bruno R, De Bartolo L, Al\u00f2 R, Canonaco M, Facciolo RM (2023) Ketogenic diet ameliorates autism spectrum disorders-like behaviors via reduced inflammatory factors and microbiota remodeling in BTBR T+ Itpr3tf\/J mice. Exp Neurol 366:114432. https:\/\/doi.org\/10.1016\/j.expneurol.2023.114432","journal-title":"Exp Neurol"},{"key":"1177_CR77","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/joim.12441","volume":"279","author":"SA Omar","year":"2016","unstructured":"Omar SA, Webb AJ, Lundberg JO, Weitzberg E (2016) Therapeutic effects of inorganic nitrate and nitrite in cardiovascular and metabolic diseases. J Intern Med 279:315\u2013336. https:\/\/doi.org\/10.1111\/joim.12441","journal-title":"J Intern Med"},{"key":"1177_CR78","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.amjcard.2005.01.082","volume":"95","author":"V Pasceri","year":"2005","unstructured":"Pasceri V, Pristipino C, Pelliccia F, Granatelli A, Speciale G, Roncella A, Pironi B, Capasso M, Richichi G (2005) Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction. Am J Cardiol 95:1358\u20131361. https:\/\/doi.org\/10.1016\/j.amjcard.2005.01.082","journal-title":"Am J Cardiol"},{"key":"1177_CR79","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11883-022-01006-w","volume":"24","author":"X Peng","year":"2022","unstructured":"Peng X, Wu H (2022) Inflammatory links between hypertriglyceridemia and atherogenesis. Curr Atheroscler Rep 24:297\u2013306. https:\/\/doi.org\/10.1007\/s11883-022-01006-w","journal-title":"Curr Atheroscler Rep"},{"key":"1177_CR80","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1111\/jcmm.13277","volume":"21","author":"C Penna","year":"2017","unstructured":"Penna C, Tullio F, Femmin\u00f2 S, Rocca C, Angelone T, Cerra MC, Gallo MP, Gesmundo I, Fanciulli A, Brizzi MF, Pagliaro P, Alloatti G, Granata R (2017) Obestatin regulates cardiovascular function and promotes cardioprotection through the nitric oxide pathway. J Cell Mol Med 21:3670\u20133678. https:\/\/doi.org\/10.1111\/jcmm.13277","journal-title":"J Cell Mol Med"},{"key":"1177_CR81","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3390\/antiox11051010","volume":"11","author":"BM Pharoah","year":"2022","unstructured":"Pharoah BM, Khodade VS, Eremiev A, Bao E, Liu T, O\u2019Rourke B, Paolocci N, Toscano JP (2022) Hydropersulfides (RSSH) outperform post-conditioning and other reactive sulfur species in limiting ischemia-reperfusion injury in the isolated mouse heart. Antioxidants (Basel) 11:1010. https:\/\/doi.org\/10.3390\/antiox11051010","journal-title":"Antioxidants (Basel)"},{"key":"1177_CR82","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/s1388-9842(02)00088-0","volume":"4","author":"C Piper","year":"2002","unstructured":"Piper C, Horstkotte D, Bock A-K, Wudel E, Schultheiss H-P, D\u00f6rner A (2002) Myocardial lactate dehydrogenase patterns in volume or pressure overloaded left ventricles. Eur J Heart Fail 4:587\u2013591. https:\/\/doi.org\/10.1016\/s1388-9842(02)00088-0","journal-title":"Eur J Heart Fail"},{"key":"1177_CR83","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1136\/heart.87.2.162","volume":"87","author":"T Reffelmann","year":"2002","unstructured":"Reffelmann T, Kloner RA (2002) The \u201cno-reflow\u201d phenomenon: basic science and clinical correlates. Heart 87:162\u2013168. https:\/\/doi.org\/10.1136\/heart.87.2.162","journal-title":"Heart"},{"key":"1177_CR84","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.3390\/jcm12144564","volume":"12","author":"C Rocca","year":"2023","unstructured":"Rocca C, Angelone T (2023) Emerging molecular determinants and protective strategies in heart disease: What\u2019s new in the Journal of Clinical Medicine? Outlook to the future. J Clin Med 12:4564. https:\/\/doi.org\/10.3390\/jcm12144564","journal-title":"J Clin Med"},{"key":"1177_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107487","volume":"94","author":"C Rocca","year":"2021","unstructured":"Rocca C, De Bartolo A, Grande F, Rizzuti B, Pasqua T, Giordano F, Granieri MC, Occhiuzzi MA, Garofalo A, Amodio N, Cerra MC, Schneider F, Panno ML, Metz-Boutigue MH, Angelone T (2021) Cateslytin abrogates lipopolysaccharide-induced cardiomyocyte injury by reducing inflammation and oxidative stress through Toll-like receptor 4 interaction. Int Immunopharmacol 94:107487. https:\/\/doi.org\/10.1016\/j.intimp.2021.107487","journal-title":"Int Immunopharmacol"},{"key":"1177_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11030571","volume":"11","author":"C Rocca","year":"2022","unstructured":"Rocca C, De Bartolo A, Granieri MC, Rago V, Amelio D, Falbo F, Malivindi R, Mazza R, Cerra MC, Boukhzar L, Lefranc B, Leprince J, Anouar Y, Angelone T (2022) The antioxidant Selenoprotein T mimetic, PSELT, induces preconditioning-like myocardial protection by relieving endoplasmic-reticulum stress. Antioxidants 11:571. https:\/\/doi.org\/10.3390\/antiox11030571","journal-title":"Antioxidants"},{"key":"1177_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/cells12071042","volume":"12","author":"C Rocca","year":"2023","unstructured":"Rocca C, De Bartolo A, Guzzi R, Crocco MC, Rago V, Romeo N, Perrotta I, De Francesco EM, Muoio MG, Granieri MC, Pasqua T, Mazza R, Boukhzar L, Lefranc B, Leprince J, Gallo Cantafio ME, Soda T, Amodio N, Anouar Y, Angelone T (2023) Palmitate-induced cardiac lipotoxicity is relieved by the redox-active motif of SELENOT through improving mitochondrial function and regulating metabolic state. Cells 12:1042. https:\/\/doi.org\/10.3390\/cells12071042","journal-title":"Cells"},{"key":"1177_CR88","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13067","volume":"223","author":"C Rocca","year":"2018","unstructured":"Rocca C, Boukhzar L, Granieri MC, Alsharif I, Mazza R, Lefranc B, Tota B, Leprince J, Cerra MC, Anouar Y, Angelone T (2018) A Selenoprotein T-derived peptide protects the heart against ischaemia\/reperfusion injury through inhibition of apoptosis and oxidative stress. Acta Physiol (Oxf) 223:e13067. https:\/\/doi.org\/10.1111\/apha.13067","journal-title":"Acta Physiol (Oxf)"},{"key":"1177_CR89","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13570","volume":"231","author":"C Rocca","year":"2021","unstructured":"Rocca C, Grande F, Granieri MC, Colombo B, De Bartolo A, Giordano F, Rago V, Amodio N, Tota B, Cerra MC, Rizzuti B, Corti A, Angelone T, Pasqua T (2021) The Chromogranin A1-373 fragment reveals how a single change in the protein sequence exerts strong cardioregulatory effects by engaging Neuropilin-1. Acta Physiol (Oxf) 231:e13570. https:\/\/doi.org\/10.1111\/apha.13570","journal-title":"Acta Physiol (Oxf)"},{"key":"1177_CR90","doi-asserted-by":"publisher","first-page":"7734","DOI":"10.1096\/fj.201802707R","volume":"33","author":"C Rocca","year":"2019","unstructured":"Rocca C, Scavello F, Colombo B, Gasparri AM, Dallatomasina A, Granieri MC, Amelio D, Pasqua T, Cerra MC, Tota B, Corti A, Angelone T (2019) Physiological levels of Chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity. FASEB J 33:7734\u20137747. https:\/\/doi.org\/10.1096\/fj.201802707R","journal-title":"FASEB J"},{"key":"1177_CR91","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1515\/BC.2001.133","volume":"382","author":"F Schliess","year":"2001","unstructured":"Schliess F, von Dahl S, H\u00e4ussinger D (2001) Insulin resistance induced by loop diuretics and hyperosmolarity in perfused rat liver. Biol Chem 382:1063\u20131069. https:\/\/doi.org\/10.1515\/BC.2001.133","journal-title":"Biol Chem"},{"key":"1177_CR92","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.2337\/dc12-1951","volume":"36","author":"RO Schlingemann","year":"2013","unstructured":"Schlingemann RO, Van Noorden CJF, Diekman MJM, Tiller A, Meijers JCM, Koolwijk P, Wiersinga WM (2013) VEGF levels in plasma in relation to platelet activation, glycemic control, and microvascular complications in type 1 diabetes. Diabetes Care 36:1629\u20131634. https:\/\/doi.org\/10.2337\/dc12-1951","journal-title":"Diabetes Care"},{"key":"1177_CR93","doi-asserted-by":"publisher","first-page":"9544","DOI":"10.1038\/s41598-021-89149-9","volume":"11","author":"JM Seefeldt","year":"2021","unstructured":"Seefeldt JM, Lassen TR, Hjortbak MV, Jespersen NR, Kvist F, Hansen J, B\u00f8tker HE (2021) Cardioprotective effects of empagliflozin after ischemia and reperfusion in rats. Sci Rep 11:9544. https:\/\/doi.org\/10.1038\/s41598-021-89149-9","journal-title":"Sci Rep"},{"key":"1177_CR94","doi-asserted-by":"publisher","DOI":"10.1111\/aas.70075","volume":"69","author":"LIP Snel","year":"2025","unstructured":"Snel LIP, Oosterom-Eijmael MJP, Lankadeva YR, Plummer MP, Preckel B, Zuurbier CJ, Hermanides J, van Raalte DH, Hulst AH (2025) Cardiovascular outcomes of perioperative Sodium-Glucose Transporter 2 inhibition in cardiac surgery patients: an open-label randomized pilot study. Acta Anaesthesiol Scand 69:e70075. https:\/\/doi.org\/10.1111\/aas.70075","journal-title":"Acta Anaesthesiol Scand"},{"key":"1177_CR95","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oeaf128","volume":"5","author":"F Solis-Jimenez","year":"2025","unstructured":"Solis-Jimenez F, Araiza-Garaygordobil D, Masso-Bueso JS, Villalobos-Ordaz A, Arellano-Juvera F, Arredondo-Aragon F, Melendez-Ramirez G, Valdez-Ortiz R, Alday-Ramirez SM, Rodriguez-Zanella HG, Amezcua Guerra LM, Arias-Mendoza MA, Martinez-Rios MA, Arias-S\u00e1nchez EA, Eid-Lidt G (2025) Effect of empagliflozin on reducing the no-reflow phenomenon in patients with ST-elevation myocardial infarction: Rationale and design of the EMPA-PCI trial. Eur Heart J Open 5:oeaf128. https:\/\/doi.org\/10.1093\/ehjopen\/oeaf128","journal-title":"Eur Heart J Open"},{"key":"1177_CR96","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.redox.2017.06.009","volume":"13","author":"S Steven","year":"2017","unstructured":"Steven S, Oelze M, Hanf A, Kr\u00f6ller-Sch\u00f6n S, Kashani F, Roohani S, Welschof P, Kopp M, G\u00f6dtel-Armbrust U, Xia N, Li H, Schulz E, Lackner KJ, Wojnowski L, Bottari SP, Wenzel P, Mayoux E, M\u00fcnzel T, Daiber A (2017) The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats. Redox Biol 13:370\u2013385. https:\/\/doi.org\/10.1016\/j.redox.2017.06.009","journal-title":"Redox Biol"},{"key":"1177_CR97","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1161\/HYPERTENSIONAHA.114.03279","volume":"63","author":"Z Szab\u00f3","year":"2014","unstructured":"Szab\u00f3 Z, Magga J, Alakoski T, Ulvila J, Piuhola J, Vainio L, Kivirikko KI, Vuolteenaho O, Ruskoaho H, Lipson KE, Signore P, Kerkel\u00e4 R (2014) Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure. Hypertension 63:1235\u20131240. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.03279","journal-title":"Hypertension"},{"key":"1177_CR98","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/cvr\/cvr053","volume":"91","author":"J-M Tang","year":"2011","unstructured":"Tang J-M, Wang J-N, Zhang L, Zheng F, Yang J-Y, Kong X, Guo L-Y, Chen L, Huang Y-Z, Wan Y, Chen S-Y (2011) VEGF\/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart. Cardiovasc Res 91:402\u2013411. https:\/\/doi.org\/10.1093\/cvr\/cvr053","journal-title":"Cardiovasc Res"},{"key":"1177_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910802","volume":"22","author":"V Thakur","year":"2021","unstructured":"Thakur V, Alcoreza N, Cazares J, Chattopadhyay M (2021) Changes in stress-mediated markers in a human cardiomyocyte cell line under hyperglycemia. Int J Mol Sci 22:10802. https:\/\/doi.org\/10.3390\/ijms221910802","journal-title":"Int J Mol Sci"},{"key":"1177_CR100","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2337\/diab.28.6.577","volume":"28","author":"W Waldh\u00e4usl","year":"1979","unstructured":"Waldh\u00e4usl W, Kleinberger G, Korn A, Dudczak R, Bratusch-Marrain P, Nowotny P (1979) Severe hyperglycemia: effects of rehydration on endocrine derangements and blood glucose concentration. Diabetes 28:577\u2013584. https:\/\/doi.org\/10.2337\/diab.28.6.577","journal-title":"Diabetes"},{"key":"1177_CR101","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000249","volume":"2","author":"W Wang","year":"2013","unstructured":"Wang W, McKinnie SMK, Patel VB, Haddad G, Wang Z, Zhabyeyev P, Das SK, Basu R, McLean B, Kandalam V, Penninger JM, Kassiri Z, Vederas JC, Murray AG, Oudit GY (2013) Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analogues. J Am Heart Assoc 2:e000249. https:\/\/doi.org\/10.1161\/JAHA.113.000249","journal-title":"J Am Heart Assoc"},{"key":"1177_CR102","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00395-025-01115-y","volume":"120","author":"M Wang","year":"2025","unstructured":"Wang M, Preckel B, Zuurbier CJ, Weber NC (2025) Effects of SGLT2 inhibitors on ion channels in heart failure: focus on the endothelium. Basic Res Cardiol 120:779\u2013798. https:\/\/doi.org\/10.1007\/s00395-025-01115-y","journal-title":"Basic Res Cardiol"},{"key":"1177_CR103","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1161\/CIRCRESAHA.110.236190","volume":"108","author":"M Wei","year":"2011","unstructured":"Wei M, Xin P, Li S, Tao J, Li Y, Li J, Liu M, Li J, Zhu W, Redington AN (2011) Repeated remote ischemic postconditioning protects against adverse left ventricular remodeling and improves survival in a rat model of myocardial infarction. Circ Res 108:1220\u20131225. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.236190","journal-title":"Circ Res"},{"key":"1177_CR104","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1053\/ajkd.1998.v32.pm9820468","volume":"32","author":"PW Wilson","year":"1998","unstructured":"Wilson PW (1998) Diabetes mellitus and coronary heart disease. Am J Kidney Dis 32:S89-100. https:\/\/doi.org\/10.1053\/ajkd.1998.v32.pm9820468","journal-title":"Am J Kidney Dis"},{"key":"1177_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101334","volume":"4","author":"Q Wu","year":"2023","unstructured":"Wu Q, Yao Q, Hu T, Yu J, Jiang K, Wan Y, Tang Q (2023) Dapagliflozin protects against chronic heart failure in mice by inhibiting macrophage-mediated inflammation, independent of SGLT2. Cell Rep Med 4:101334. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101334","journal-title":"Cell Rep Med"},{"key":"1177_CR106","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE, EMPA-REG OUTCOME Investigators (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373:2117\u20132128. https:\/\/doi.org\/10.1056\/NEJMoa1504720","journal-title":"N Engl J Med"},{"key":"1177_CR107","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1080\/21655979.2022.2033411","volume":"13","author":"W Zou","year":"2022","unstructured":"Zou W, Liu B, Wang Y, Shi F, Pang S (2022) Metformin attenuates high glucose-induced injury in islet microvascular endothelial cells. Bioengineered 13:4385\u20134396. https:\/\/doi.org\/10.1080\/21655979.2022.2033411","journal-title":"Bioengineered"}],"container-title":["Basic Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-026-01177-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00395-026-01177-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-026-01177-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:23:54Z","timestamp":1779200634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00395-026-01177-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":107,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["1177"],"URL":"https:\/\/doi.org\/10.1007\/s00395-026-01177-6","relation":{},"ISSN":["1435-1803"],"issn-type":[{"value":"1435-1803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}